why choose us

First received: July 29, 2022

Clinical Trial: BIOSTEMI Extended Survival

Study Status: Active, not recruiting

Recruit Status: Active, not recruiting

Condition: Coronary Artery Disease
Acute Coronary Syndrome

Study Type: Observational


Official Title: Randomized Multicenter Comparison Between Ultrathin-strut Biodegradable Polymer Sirolimuseluting Stents and Durable Polymer Everolimus-eluting Stents for Patients With Acute ST-segment Elevation Myoca

Brief Summary: The objective of the BIOSTEMI ES study is to assess the long-term clinical outcomes with the Orsiro ultrathin-strut biodegradable polymer sirolimus-eluting stent compared to the Xience thin-strut durable polymer everolimus-eluting stent up to 5 years of follow-up among patients with STEMI undergoing primary PCI, enrolled in the BIOSTEMI trial.

Read more